Krystal Biotech, Inc.
Commercial-stage biotech developing genetic medicines for severe and rare diseases.
KRYS | US
Overview
Corporate Details
- ISIN(s):
- US5011471027
- LEI:
- Country:
- United States of America
- Address:
- 2100 WHARTON STREET, 15203 PITTSBURGH
- Website:
- https://www.krystalbio.com/
- Sector:
- Manufacturing
Description
Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, and commercializes genetic medicines for severe, life-threatening, or rare diseases with high unmet medical needs. The company utilizes a proprietary, redosable gene therapy platform to deliver transformative treatments. Krystal has an FDA-approved product and maintains a robust pipeline of drug candidates across several therapeutic areas, including dermatology, respiratory, oncology, ophthalmology, and aesthetics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Krystal Biotech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Krystal Biotech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Krystal Biotech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
